Inositol(myo)-1(or 4)-Monophosphatase 2 (IMPA2) Peptid
IMPA2
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle IMPA2 Produkte
- IMPA2 (Inositol(myo)-1(or 4)-Monophosphatase 2 (IMPA2))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-IMPA2 antibody (Catalog #: ARP58229_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- IMPA2 (Inositol(myo)-1(or 4)-Monophosphatase 2 (IMPA2))
- Synonyme
- zgc:110201 Peptide, 2210415D20Rik Peptide, AI326924 Peptide, AW259601 Peptide, inositol monophosphatase 2 Peptide, inositol(myo)-1(or 4)-monophosphatase 2 Peptide, inositol (myo)-1(or 4)-monophosphatase 2 Peptide, IMPA2 Peptide, impa2 Peptide, MGYG_08537 Peptide, Impa2 Peptide
- Hintergrund
-
IMPA2 belongs to the inositol monophosphatase family. The present study suggests that a promoter haplotype of IMPA2 possibly contributes to risk for bipolar disorder by elevating IMPA2 levels in the brain, albeit the genetic effect varies among populations.
Alias Symbols: -
Protein Interaction Partner: HERPUD1
Protein Size: 288 - Molekulargewicht
- 32 kDa
- Gen-ID
- 3613
- NCBI Accession
- NM_014214, NP_055029
- UniProt
- O14732
-
Sie sind hier:
